We have previously described the role of red hair (melanocortin-1 receptor, MC1R) and blue eye (oculocutaneous albinism type II, OCA2) gene polymorphisms in modulating the risk of cutaneous malignant melanoma (CMM) in a highly sun-exposed population of European descent. A number of recent studies, including genome-wide association studies, have identified numerous polymorphisms controlling human hair, eye, and skin color. In this paper, we test a selected set of polymorphisms in pigmentation loci (ASIP (Agouti signalling protein, nonagouti homolog (mouse) gene), TYR (tyrosinase), TYRP1 (tyrosinase-related protein 1), MC1R, OCA2, IRF4 (interferon regulatory factor 4), SLC24A4 (solute carrier family 24, member 4), and SLC45A2 (solute carrier family 45, member 2)) for association with CMM risk in a large Australian population-based case-control study. Variants in IRF4 and SLC24A4, despite being strongly associated with pigmentation in our sample, did not modify CMM risk, but the other six did. Three single nucleotide polymorphisms (rs28777, rs35391, and rs16891982) in the MATP gene (SLC45A2) exhibited the strongest crude association with risk, but this was attenuated to approximately the same effect size as that of a MC1R red hair color allele by controlling for ancestry of cases and controls. We also detected significant epistatic interactions between SLC45A2 and OCA2 alleles, and MC1R and ASIP alleles. Overall, these measured variants account for 12% of the familial risk of CMM in our population.
INTRODUCTION
Cutaneous malignant melanoma (CMM) is a common cancer in the fair-skinned population of tropical and subtropical Queensland, Australia, with an estimated lifetime risk of 5% (Queensland Cancer Registry, 2008) . Within the fairer skinned populations, risk varies with the degree of paleness as well as with other pigmentation phenotypes, such as hair and eye color, all of which are strongly genetically determined.
We have previously described association between variants in the pigmentation genes encoding the melanocortin-1 receptor (MC1R) (Palmer et al., 2000; Box et al., 2001 ) and the human melanocyte-specific P-protein (oculocutaneous albinism type II, OCA2) with CMM risk (Sturm et al., 2008) . A number of recent genome-wide association studies have characterized variants in both known pigmentation pathways (TYR (tyrosinase), TYRP1 (tyrosinase-related protein 1), and SLC45A2 (solute carrier family 45, member 2)) (Sulem et al., 2007; Sulem et al., 2008) and previously unknown (IRF4 (interferon regulatory factor 4) and SLC24A4 (solute carrier family 24, member 4)) (Sulem et al., 2007; Han et al., 2008) genes that influence pigmentation, and one study has reported on associations with CMM . Association with both pigmentation and CMM risk (Brown et al., 2008; Gudbjartsson et al., 2008) has also been reported for variants in a region of chromosome 20 fairly close to the human homologue of the mouse Agouti gene (ASIP).
Variants in many of these genes exhibit significant differences in frequency, and underlie the pigmentation differences, between different ethnic groups. It is important, therefore, to differentiate between disease associations due to a direct genotype-phenotype relationship, and those due to confounding by ancestry.
Here, we replicate and extend association results with CMM to MC1R, OCA2, TYR (OCA1), TYRP1 (OCA3), IRF4, SLC24A4, SLC45A2 (MATP, OCA4), and ASIP, and examine the nature of interaction between these loci on disease risk in a large sample from a population at high environmental and genetic risk of melanoma.
RESULTS
There were 1,738 CMM cases and 4,517 controls. Ancestry and coloring for the sample are shown in Table 1 . Differences between cases and controls are in the expected direction, as reported previously for this sample (Palmer et al., 2000) , with cases tending to have lighter colored eyes and hair. Participants were genotyped at up to 161 single nucleotide polymorphisms (SNPs) across the gene regions of interest (Supplementary Table 1 ). Table 2 shows case and control allele frequencies and Hardy-Weinberg equilibrium tests for selected SNPs. A number of SNPs exhibited extreme Hardy-Weinberg disequilibrium, but as the chosen SNPs are located in pigmentation loci that are known to be highly informative for coloring and ancestry, it could be shown that the disequilibrium was due to ethnic stratification of the sample rather than to genotyping error (see Supplementary  Table 2) .
One or more of the SNPs selected in each gene region could be shown to be associated with skin, hair, or eye color (Table 3) , and in the subsequent analyses, we only present results for association with CMM for the polymorphisms most penetrant for pigmentary characteristics from each gene. In keeping with the selection criteria, a number of these SNPs were also strongly associated with the reported ancestry (see Supplementary Table 2) . Among the CMM cases with ancestry information, only 2.7% reported other than 100% Northern European ancestry, as compared with 13.5% of the control sample. To control these effects on CMM association analyses given below, we report analyses on the subset of 1,438 cases and 3,098 controls reporting four grandparents of Northern European ancestry. We found that further inclusion of an ancestry indicator for English, Scottish/ Welsh/Irish, and continental Europe as a covariate did not detect finer levels of ethnic confounding on CMM association. Interestingly, rs12203592 (in IRF4) did exhibit significant allele frequency differences between controls from continental Europe, England and Scotland, Ireland and Wales, but these could be safely ignored given that this locus does not exhibit significant association with CMM (see below).
In univariate analyses, MC1R, ASIP, TYRP1, (IRF4), and SLC45A2 SNPs were the markers most strongly associated with CMM risk in terms of crude risk (Table 4) . Given the starshaped genealogy of MC1R red-hair-associated haplotypes (that is, all these coding variants are in complete negative linkage disequilibrium; in our population we have observed only three haplotypes with more than one coding variant present), we have recoded MC1R haplotypes as ''R'' (high red hair penetrance: rs1805006 (D84E), rs11547464 (R142H), rs1805007 (R151C), rs1805008 (R160W), and rs1805009 (D294H)) and ''r'' (low red hair penetrance: rs1805005, rs2228479, and rs885479) (Sturm et al., 2003) for this and subsequent analyses. On restricting the case-control analysis only to individuals reporting all four grandparents to be of Northern European ancestry, the significant predictors of CMM risk were four ''R'' SNPs in MC1R (rs1805007, rs1805008, rs1805006, and rs11547464); the three SLC45A2 SNPs; rs1126809 in TYR; and rs4911442 in the region of ASIP. In the case of SLC45A2, the three SNPs were in very strong disequilibrium, and the noncoding SNPs, rs35391 and rs28777, were not significant melanoma risk predictors in multivariate logistic regression models after adjusting for rs16891982.
When we further adjusted for hair, eye, and skin color, several SNPs exhibited a persistent association, suggesting that they act as mediating variables (Table 4) between ancestry and melanoma risk. The TYR coding SNP, rs1126809, remained important, but rs12913832 in OCA2 (a regulatory SNP actually located in an intron of the adjacent HERC2 gene, but the main determinant of blue eye color, Sturm et al., 2008) and the TYRP1 SNPs were less impressive as CMM risk factors. The effect of OCA2*R419Q was relatively small in its own right. When we combine the strongest associated SNPs from TYR, SLC45A2, OCA2, MC1R, and ASIP in a multivariate logistic regression (Table 5) , this gives a Nagelkerke R 2 index ¼ 0.059. For comparison, a regression including eye, skin, and hair color obtained R 2 ¼ 0.048, and supplementing this with the genotype data increased the R 2 to 0.08. As logistic regression R 2 -values are difficult to interpret (Nagelkerke 1991) , we also present locus-specific sibling recurrence risk ratios (l S ). Under the usual multiplicative model assumption, these can be multiplied to give a total contribution of 1.14 to the sibling recurrence risk. We can calculate the equivalent contribution of measured pigmentation phenotype (skin, hair, and eye color) at 1.37, so that the current SNPs explain B43% of the effects of pigmentation on familial risk (log(1.15)/log(1.37)) and B15% of the total observed sibling risk l S ¼ 2.49 estimated previously in our population (Do et al, 2004) . In analyses including pairwise interactions, we observed an interaction only between OCA2*R419Q and rs1126809 (P ¼ 0.01, Supplementary Table 3), although there was a suggestive pattern of interaction between MC1R and ASIP genotypes and CMM, which mirrored a highly significant interaction between these loci in their effects on the red hair color ( Table 6) .
As we noted elsewhere (Brown et al., 2008) , a number of SNPs spread over the region around ASIP exhibit association with CMM, and the analyses above have concentrated on rs4911442 only because it is genotyped in more controls than the other peak SNPs. The pattern of linkage disequilibrium around ASIP is quite complex, with ''hotspots'' just distal to the gene and 70 kbp proximal (see Figure 1) , and the pattern of individual SNP association with CMM and with red hair color is bimodal, dipping rather than rising over ASIP.
Examining haplotypes that are comprised of 31 SNPs spanning from rs17305657 to rs1885120 (a distance of 1.77 Mbp) revealed that the commonest haplotype (present in 4% of controls) is significantly increased in CMM cases (7.3%, odds ratio ¼ 1.89; see Supplementary Table 4 ). This haplotype is tagged by the SNPs that are most strongly individually associated with CMM (including rs4911442). When analysis is restricted just to six tagging SNPs, there are eight haplotypes present at greater than 1% study frequency, one (78% of control samples) being significantly increased in controls and three (3.8%, 3.9%, 0.6%) increased in cases
). The latter three share only the distal three markers in common; hence the most likely location for the susceptibility locus lies downstream to ASIP.
Using a publicly available US population genome-wide association studies data set (Simon-Sanchez et al., 2007), we were able to show that the peak CMM SNP set described by Gudbjartsson et al. (2008) was in strong linkage disequilibrium with rs4911442, despite being 600 kbp distant (P ¼ 4 Â 10
À13
). Specifically, an individual carrying the G-A risk haplotype defined by Gudbjartsson et al. (2008) had a 50% probability of carrying the rs4911442*C on that haplotype, whereas the other three haplotypes were associated with rs4911442*T in 99% of cases. The letter i denotes intron, so HERC2 i86 denotes the 86th intron of the HERC2 gene.
2
Actually present in intron of NCOA6, 500 kbp distal to ASIP.
DISCUSSION
This paper attempts to address two topics. The first is to confirm and quantify the overall contribution of currently recognized pigmentation loci to variation in risk of cutaneous melanoma. Second, we expand the evidence of the recently recognized association between SNPs near ASIP and CMM, and attempt to reconcile results from different studies Brown et al., 2008) . We have replicated association of SNPs at our chosen loci MC1R, OCA2, ASIP, SLC45A2, SLC24A4, TYR, TYRP1, and IRF4 with skin, hair, and eye color, and shown that most of these SNPs are also significant predictors of CMM risk in our population. As some SNPs are not genotyped in all subjects, the data set suitable for multivariate analysis is reduced; hence the confidence intervals around simultaneously adjusted effect sizes are broader than that for (most of) the univariate analyses. The pattern is broadly consistent with multiplicative epistasis, with only weak evidence for nonmultiplicative interactions. The combination of SNPs in the five associated loci (MC1R, SLC45A2, OCA2, TYR, and ASIP) explains roughly one-third to one-half of the variation in risk due to observed pigmentation phenotype. Pigmentation phenotype itself explains approximately one-third of the familial aggregation of melanoma. By contrast, the highpenetrance CDKN2A mutations segregating in families with multiple cases of melanoma explain only 0.1% of recurrence risk in the total population. This is because they are extremely rare and involved in 0.2% of all Queensland melanoma cases (Aitken et al., 1999) , with an allele frequency of B5 Â 10 À6 . Attributable risk is another measure of the importance of a risk locus, but is not completely satisfactory, in that genotypes that are rare in our population may offer the lowest absolute reduction in risk (for example, the rare protective allele in SLC45A2). This is only the third study reporting an association between SLC45A2 and CMM. Fernandez et al. (2008) genotyped the coding polymorphism rs16891982 (F374L) in a collection of Spanish CMM cases and controls, whereas Guedj et al. (2008) report results from a French case-control study. In keeping with our findings, the minor (L374) allele was protective (7% frequency in Spanish cases and 16% frequency in Spanish controls; 4% and 10% in the French sample). This protective allele is associated with olive and dark skin, and hence is least common in Northern European populations (1.7% in the Utah-derived CEU HapMap sample), more common in Southern Europeans, but is fixed in African and most Asian populations (Yuasa et al., 2006) . In our Australian sample, examination of the three SNP haplotypes and logistic regression analysis showed that rs16891982 is the SNP most strongly associated with melanoma risk in our population.
The variant in the TYR most strongly associated with CMM risk by Gudbjartsson et al. (2008) was rs1126809 (R402Q). We found a significant association with rs1126809, and any association with the intronic SNP rs10765198 disappeared in multivariate models in which rs1126809 was included as a covariate. The Q402 variant form of TYR has 25% of the catalytic activity of the R402 form at 37 1C (Tripathi et al., 1991) , and causes autosomal recessive ocular albinism when co-occurring with more penetrant OCA mutations in compound heterozygote form (Fukai et al., 1995; Hutton and Spritz, 2008) . It is therefore a strong candidate for the causative risk variant in this gene. Similar to Gudbjartsson et al. (2008) , we did not detect any association between rs1042602 (TYR*S192Y) and CMM in our Australian sample, even though those authors did detect an association with freckling in their Scandinavian sample. In the case of OCA2, we found that the SNP (rs12913832), most strongly associated with blue eye color in our sample (Sturm et al., 2008) , was not associated with CMM, especially after adjusting for ancestry. Rather, the less common coding mutation R419Q (rs1800407) was a significant risk factor, notably in the multivariate analysis adjusted for other pigmentation loci. This association has also been seen in a Spanish data set (Fernandez et al., 2009 ) with similar effect sizes. In the French case-control study of Jannot et al. (2005) , R419Q was not a significant risk factor for melanoma, but the nearby R305W and neighboring intronic SNPs were. The R305W and R419Q variants are in complete linkage disequilibrium in our population. The OCA2 variants screened by Gudbjartsson et al. (2008) were not associated with CMM.
The TYRP1 (OCA3) variants we genotyped have been previously shown to be associated with eye and hair color , and with CMM risk . We confirmed these associations and effect size estimates. These variants differ significantly in frequency between the main HapMap ethnic samples, and we could show a gradient with a proportion of Northern European ancestry paralleling hair and eye color. We did not detect specific interactions between TYR and TYRP1 in their effects on melanoma risk or on pigmentation phenotypes.
The two recent reports of association of SNPs located in the region of ASIP with CMM risk Brown et al., 2008) implicated widely separated SNPs. We observed that the association of CMM with the ASIP region closely paralleled that with red hair color, and seems to be largely due to a single long (B1.8 Mb) haplotype that straddles a number of haplotype block boundaries. This is likely to represent the effects of selection along with a relatively recent origin, as has been observed around other pigmentation loci (Barreiro et al., 2008) , given that this particular haplotype is also associated with lighter hair and skin color.
Given the role of ASIP as an antagonist of the melanocortin pathway, it seems biologically plausible that there would be an interaction between MC1R genotype and ASIP genotype. For red hair color, this was markedly so, with the rs4911442*C allele being roughly equivalent to an ''r'' MC1R haplotype. This is most easily seen by comparing the penetrances of the joint ''R/w; C/T'' genotype with the ''R/r; T/T'' genotype, and in the linear dose-response relationship between number of rs4911442*C alleles on an ''R/r'' back- Five categories (fair, light brown, red, dark brown, and black); reference category, fair.
4 P-value from sequential likelihood ratio test.
5
Three categories (light, medium, and dark); reference category, light.
6
Three categories (blue/grey, green/hazel, and brown/black); reference category, blue/grey.
www.jidonline.org 525 ground (Table 6 ). In the same fashion, MC1R ''R'' haplotypes were dominant to rs4911442*C. Therefore, ASIP is a red hair color locus, in the same way as MC1R. In keeping with this, rs4911442 genotype was a significant predictor of facial freckling (P ¼ 0.0001), as noted by others . A similar pattern was observed for CMM, but did not reach formal statistical significance. The association signal for red hair color and CMM across chromosome 20 did track quite strongly, so we expect that the epistatic pattern seen for these two loci with respect to hair color would also be demonstrable for CMM given a larger sample size. An interesting negative finding in this study is the absence of an association between IRF4 genotype and melanoma risk, despite the very strong evidence for association of this locus with skin coloring in this and other studies (Han et al., 2008; Sulem et al., 2008) . This was also noted by Gudbjartsson et al. (2008) , and is in some ways the obverse of our previous observation (Palmer et al., 2000) that some pigmentation loci, such as MC1R, seem to affect CMM risk by pathways other than that mediated by measurable changes in skin coloring or tanning ability. Here, we observe an effect on coloring, which one would expect to significantly influence response of the organism to exposure to ultraviolet light, but appears neutral with respect to CMM risk. In the case of OCA2, we and others have previously described how a single SNP rs12913832 strongly predicts eye color (Sturm et al., 2008; Kayser et al., 2008; Eiberg et al., 2008) , but has little or no effect on CMM risk. We do see an effect of another OCA2 polymorphism rs1800407 on CMM risk, but this is less impressive in terms of statistical significance.
A peculiarity of these analyses is that most of these pigmentation loci markedly differ in allele frequencies between different ethnic groups, in a way that parallels the differences in CMM rates between these groups. The simplest hypothesis, given that we have shown that all the selected variants are associated with pigmentation, is that these variants underlie ethnic variation in CMM risk. To definitively exclude ethnic confounding as a cause of the observed association between ancestry informative variants and disease risk, we would need either a cohort design, in which we could show that the rate of CMM in carriers of all low-risk variants is comparable with that seen in ethnic groups of known low ''intrinsic'' risk, or a family-based design, in which we could also show linkage of these variants. Unfortunately, the age of onset of CMM in our sample and sampling design means that we cannot pursue the latter strategy, although we can show significant transmissiondisequilibrium test results for pigmentation phenotypes, such as skin coloring.
In conclusion, the variants in pigmentation genes that we describe explain B40% of the variation in familial risk of melanoma ascribable to phenotypes, such as skin, hair, and eye color. In the cases of TYR, SLC45A2, OCA2, and MC1R, it is likely that the major causative risk variants have been identified, but this is still open for ASIP, and other minor risk variants at all loci await characterization.
MATERIALS AND METHODS

Study participants
Cutaneous malignant melanoma cases were a stratified sample of all cases of CMM diagnosed in the state of Queensland between the period 1982 and 1990, as described in detail elsewhere (Baxter et al., 2008) . These individuals were originally studied from 1991 to 1994, but were recontacted and interviewed between 2002 and 2004.
The controls for the present analysis came from the Brisbane Twin Nevus Study. As described in detail elsewhere (Sturm et al., 2008) , adolescent twins, their siblings, and parents have been recruited over 16 years into an ongoing study of genetic and environmental factors contributing to the development of pigmented nevi and other risk factors for skin cancer. The proband twins are recruited at the age of 12 years through schools around Brisbane, Australia, and followed up at the age of 14 years. All controls are screened to be unaffected by CMM. The sample is overwhelmingly (495%) of Northern European origin (mainly Anglo-Celtic). All cases and controls gave informed consent to participate in this study, and the study protocol was approved by appropriate institutional review boards and adhered to the Helsinki Guidelines. Ancestry was measured by questioning either the individual or a parent about the country of birth and ancestry of each of the grandparents of the individual. As most subjects were of European ancestry, we have constructed three ancestry scores on the basis of the proportion of grandparents of Northern European (British, Scandinavian, Danish, Dutch, German, and French), Southern European (Spanish, Italian, and Greek), and Eastern European ancestry. In addition, the Northern indicator was supplemented by ''Celtic'' (Ireland, Scotland, and Wales), English, and Continental indicators, to test whether there were further substructure effects. Ancestry data is available for all cases and controls included in these analyses.
Genotyping and statistical analysis
We selected SNPs for association testing based on association with pigmentation phenotypes in our own and other studies (Palmer et al., 2000; Sturm et al., 2008; Sulem et al., 2007; Han et al., 2008) . In the case of SNPs near ASIP (Brown et al., 2008) , we had observed maximal association with CMM at SNPs away from ASIP itself, hence the two SNPs reported to be most strongly associated to CMM in the study of Gudbjartsson et al. (2008) were not genotyped. We did not genotype within SLC24A5 (''Golden''), given that the variant associated with human skin color is almost monomorphic in whites. SNPs were typed using iPLEX Gold chemistry on a MALDI-TOF Mass Spectrometer (Sequenom, San Diego, CA). PCR was carried out using a 2.5-ml reaction mixture in standard 384-well plates. PCR was performed using 10 ng genomic DNA, 0.5 unit of Taq polymerase (HotStarTaq, Qiagen, Valencia, CA), 500 mmol of each dNTP, and 100 nmol of each PCR primer. PCR thermal cycling in an ABI-9700 instrument was 15 minutes at 94 1C, followed by 45 cycles of 20 sec at 94 1C, 30 seconds at 56 1C, and 60 seconds at 72 1C. To the completed PCR mixture, 1 ml containing 0.15 units of Shrimp alkaline phosphatase was added and the mixture incubated for 30 minutes at 37 1C followed by inactivation for 5 minutes at 85 1C. After adjusting the concentrations of extension primers to equilibrate signal-to-noise ratios, the post-PCR primer extension reaction of the iPLEX assay was performed in a final 5 ml volume extension reaction containing 0.1 ml of termination mix, 0.02 ml of DNA polymerase (Sequenom), and 600-1,200 nM extension primers. A two-step 200 short cycles program was used for the iPLEX reaction: initial denaturation was 30 seconds at 94 1C followed by five cycles of 5 seconds at 52 1C and 5 seconds at 80 1C. An additional 40 annealing and extension cycles were then looped back to 5 seconds at 94 1C, 5 seconds at 52 1C, and 5 seconds at 80 1C. The final extension was carried out at 72 1C for 3 minutes and the sample was cooled to 20 1C. The iPLEX reaction products were desalted by diluting samples with 15 ml of water and adding 3 ml of resin, and centrifuged to remove resin. The products were spotted on a SpectroChip (Sequenom), processed, and analysed in a Compact Mass Spectrometer using MassARRAY Workstation (version 3.3) software (Sequenom). As genotyping has been carried out in various subsets of the data, the number of genotyped cases and controls varies from marker to marker. Specifically, some markers are genotyped in the entire collection, whereas others have been genotyped only in a nested sample of unrelated cases and controls.
As some cases (105 individuals) are from 48 multiplex families and all our controls come from twin families, the association analyses were carried out using Sib-pair 1.0 (Duffy, 2008) . The association analysis in Sib-pair implements a logistic regression penetrance analysis of measured genotypes within pedigrees that may include monozygotic twins, and uses Monte Carlo (gene-dropping) simulation www.jidonline.org 527 DL Duffy et al.
to obtain P-values adjusted for the relationships of cases and controls. Other analyses have been carried out in the R statistical analysis environment (R Core Development Team, 2008) , using especially the haplo.stats package (Sinnwell et al., 2007) , and also using Haploview (Barrett et al., 2005) to generate plots and long-range haplotypes. We express the overall contribution of the measured loci to risk of melanoma in logistic regression analyses as the Nagelkerke R 2 (Nagelkerke 1991), and have also calculated the locus-specific sibling recurrence risk (James, 1971; Risch, 1990 ) predicted for that locus under an assumed lifetime risk of 5.2% (Queensland Cancer Registry, 2008) . This further assumes that a proportional hazards model is appropriate, but is quite robust to the assumed lifetime risk.
